Clinical Definition

ASV is a sophisticated ventilatory support system that provides variable pressure support based on the patient's breathing patterns. The device continuously monitors the patient's ventilation and adjusts support to maintain a target ventilation level.

Key features of ASV include:

  • Adaptive Algorithm: Continuously calculates target ventilation based on recent breathing patterns
  • Variable Pressure Support: Adjusts inspiratory pressure support breath-by-breath
  • Fixed EPAP: Maintains consistent expiratory pressure to prevent upper airway collapse
  • Backup Rate: Provides machine-triggered breaths if spontaneous breathing ceases

ASV is particularly effective for treating central sleep apnea and complex sleep apnea syndrome.

Etymology & History

ASV technology was developed in the early 2000s as a response to the limitations of traditional PAP therapy for central sleep apnea. The first ASV devices became commercially available in the mid-2000s, offering a targeted treatment for complex breathing disorders.

Reference Values & Interpretation

Normal Values

ASV settings typically include an EPAP of 5-15 cm H2O and variable inspiratory pressure support. The device automatically adjusts the level of support based on the patient's breathing patterns and calculated target ventilation.

Abnormal Values

Inadequate ASV settings may result in persistent central apneas or insufficient ventilatory support. Over-support can lead to hyperventilation and paradoxically worsen central apneas in some patients.

How It's Measured

ASV settings are determined during an in-lab titration study. The technician sets the EPAP level to eliminate obstructive events while allowing the ASV algorithm to automatically adjust pressure support for central events.

Role in Diagnosis

ASV is used when other forms of PAP therapy are ineffective for central sleep apnea or complex sleep apnea syndrome. It's particularly useful for patients who develop treatment-emergent central apneas on CPAP therapy.

Role in Treatment

ASV is the preferred treatment for complex sleep apnea syndrome and many forms of central sleep apnea. However, it's contraindicated in patients with chronic heart failure with reduced ejection fraction due to increased mortality risk shown in clinical trials.

Associated Conditions

bipap|central-sleep-apnea|complex-sleep-apnea|servo-ventilation

">

Clinical Guidelines

[{"guideline_title":"AASM Clinical Practice Guideline for ASV Therapy","guideline_link":"/clinical/guidelines/aasm-asv/"}]

Latest Research & Updates

AI-Updated Weekly

Recent clinical trials have shown that ASV is contraindicated in patients with chronic heart failure and reduced ejection fraction due to increased cardiovascular mortality. This has led to more careful patient selection and monitoring protocols.